Search Results 1061-1070 of 18022 for Lupus

1. Adalimumab-atto (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Some people who have used this medicine developed lupus-like symptoms during treatment and got better after the medicine was stopped. Check with your doctor ...

2. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   ... lupus erythematosus (SLE), rheumatoid arthritis, connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis ...

3. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   ... lupus erythematosus; Wegener's granulomatosis; myasthenia gravis; Graves' disease; rheumatoid arthritis; hypophysitis; uveitis; etc) within the past 3 years ...

4. A Study to Establish an Alcoholic Hepatitis Network - Mayo Clinic

   Immune related conditions (such as Crohn's disease, rheumatoid arthritis, ulcerative colitis, systemic lupus erythematosus, severe psoriasis, etc.). Known ...

5. Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients - Mayo Clinic

   ... lupus, or pneumonitis, with the exception of hypothyroidism and type 1 diabetes that are controlled with treatment 13. Immunodeficiency or immunosuppression ...

6. Atezolizumab (intravenous route) - Side effects & uses - Mayo Clinic

   Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Infection or; Liver problems or; Lung or breathing problems or; Nervous system ...

7. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

   ... lupus erythematosus) 3. Primary diagnosis of myocarditis (diagnosis of myopericarditis is accepted) 4. Estimated glomerular filtration rate (eGFR) \< 30 mL ...

8. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   ... lupus erythematosus (SLE), connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients ...

9. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid - Mayo Clinic

   ... lupus, inflammatory bowel disease, rheumatoid arthritis, etc.), other severe endocrinological, gastrointestinal, hepatobiliary, metabolic, pulmonary, or ...

10. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    History or risk of autoimmune disease, including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease ...